CounterPath Reports First Quarter Fiscal 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CounterPath Reports First Quarter Fiscal 2017 Financial Results

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 14, 2016) - CounterPath Corporation ("CounterPath" or the "Company") (NASDAQ:CPAH)(TSX:CCV), a global provider of award-winning over-the-top (OTT) Unified Communications solutions for enterprises and carriers, today announced the financial and operating results for its first quarter ended July 31, 2016 of fiscal year 2017.

First Quarter Financial Highlights (unaudited)

  • Growth in revenue of 28% with quarterly revenue of $3.0 million compared to revenue of $2.4 million for the first quarter of fiscal 2016.
  • Growth in subscription, support and maintenance revenue (revenue of a recurring nature) of 14% for the quarter compared to first quarter of fiscal 2016.
  • Gross margin of 84% compared to 80% for the first quarter of fiscal 2016.
  • Non-GAAP loss from operations of $0.3 million compared to non-GAAP loss from operations of $1.2 million for the first quarter of fiscal 2016.
  • Net loss of $0.4 million, or $0.08 per share, compared to a net loss of $1.1 million, or $0.26 per share, for the first quarter of fiscal 2016.
  • Non-GAAP net loss of $0.0 million, or $0.01 per share, compared to non-GAAP net loss of $0.7 million, or $0.17 per share, for the first quarter of fiscal 2016.
  • Cash of $2.2 million as of July 31, 2016 compared to cash of $2.2 million as of April 30, 2016.

Management Commentary

"During the last quarter, the Company recorded year-over-year growth in revenue of 28% while reducing costs and managing cash" said Donovan Jones, President and Chief Executive Officer. "We are pleased with the progress we continue to make on growing our recurring revenue with the recent launch of Bria for Salesforce and the Beta of Bria X, for which we expect the full launch to be in the current quarter. Bria X is a Software-as-a Service (SaaS) solution that enables enterprises to communicate and collaborate better in a global, secure and productive environment. This subscription based offering is targeted towards new users of the SMB market as well as our extensive existing user base of X-lite and Bria. Bria X offers greater value as we have new services attached to Bria X including secure corporate instant messaging, screen sharing and message synchronization, all hosted by CounterPath from the cloud," continued Jones.

Recent Business Highlights

  • Showcased the Company's Bria and Stretto suite at the Aspect Customer Experience (ACE) 2016 conference in Las Vegas, NV, demonstrating key partner integrations, such as CRM.
  • Announced that a current customer who has generated over $1.1 million in revenue for the Company, and a leading cloud contact center solutions provider, has standardized on its customized version of CounterPath's Bria desktop softphone.
  • Announced its new Bria for Salesforce application is now available through the Salesforce AppExchange, empowering Salesforce users to connect with customers, partners and employees.

Financial Overview

(All amounts in U.S. dollars and in accordance with accounting principles generally accepted in the United States ("GAAP") unless otherwise specified - unaudited. Per share figures reflect the impact of a one-for-ten reverse stock split effected at the opening of trading on November 2, 2015 which has been retroactively applied to the figures in this new release and the consolidated financial statements.)

Revenue was $3.0 million for the quarter ended July 31, 2016 compared to $2.4 million for the same quarter last fiscal year. Software revenue was $1.7 million compared to $1.2 million for the same quarter last fiscal year, subscription, support and maintenance revenue was $1.0 million compared to $0.8 million for the same quarter last fiscal year, and professional services and other revenue was $0.4 million compared to $0.3 million for the same quarter last fiscal year.

Operating expenses for the quarter ended July 31, 2016 were $3.6 million compared to $3.9 million for the same quarter last fiscal year. Approximately $0.1 million of the $0.3 million decline in operating expenses was related to a weakening Canadian dollar relative to the U.S. dollar as a significant percentage of the Company's operating costs are based in Canadian dollars. Operating expenses for the quarter ended July 31, 2016 included a non-cash stock-based compensation expense of $0.3 million (2016 - $0.4 million). Sales and marketing expenses were $1.0 million for the quarter ended July 31, 2016 compared to $1.2 million for the same quarter last fiscal year. For the quarter ended July 31, 2016, research and development expenses were $1.2 million and general and administrative expenses were $1.0 million compared to $1.3 million and $0.9 million, respectively, for last fiscal year.

Foreign exchange gain for the quarter ended July 31, 2016 was $0.2 million compared to $0.5 million for the same quarter last fiscal year. The foreign exchange gain represents the gain on account of translation of the intercompany accounts of CounterPath's subsidiary which are maintained in Canadian dollars and transactional gains and losses resulting from transactions denominated in currencies other than U.S. dollars.

The net loss for the quarter ended July 31, 2016 was $0.4 million, or ($0.08) per share, compared to a net loss of $1.1 million, or ($0.26) per share, for the same quarter last fiscal year. As of July 31, 2016, the Company had $2.2 million in cash, compared to $2.2 million at April 30, 2016.

Forward-Looking Statements

This news release contains "forward-looking statements". Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including (1) the Company's expectation of the full launch of Bria X to be in the current quarter. It is important to note that actual outcomes and the Company's actual results could differ materially from those in such forward-looking statements. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others: (1) the variability in CounterPath's sales from reporting period to reporting period due to extended sales cycles as a result of selling CounterPath's products through channel partners or the length of time of deployment of CounterPath's products by its customers, (2) the Company's ability to manage its operating expenses, which may adversely affect its financial condition, (3) the Company's ability to remain competitive as other better financed competitors develop and release competitive products, (4) a decline in the Company's stock price or insufficient investor interest in the Company's securities which may impact the Company's ability to raise additional financing as required or be delisted from a stock exchange on which its common stock trades, (5) the impact of intellectual property litigation that could materially and adversely affect CounterPath's business, (6) the success by the Company of the sales of its current and new products, (7) the impact of technology changes on the Company's products and industry, (8) the failure to develop new and innovative products using the Company's technologies, and (9) the potential dilution to shareholders or overhang on the Company's share price of its outstanding stock options. Readers should also refer to the risk disclosures outlined in the Company's quarterly reports on Form 10-Q, or in the annual reports on Form 10-K, and the Company's other disclosure documents filed from time-to-time with the Securities and Exchange Commission at http://www.sec.gov and the Company's interim and annual filings and other disclosure documents filed from time-to-time on SEDAR at www.sedar.com .

About CounterPath

CounterPath Unified Communications solutions are changing the face of telecommunications. An industry and user favorite, Bria softphones for desktop, tablet and mobile devices, together with Stretto Platform™ server solutions, enable operators, OEMs and enterprises large and small around the globe to offer a seamless and unified over-the-top (OTT) communications experience across both fixed and mobile networks. The Bria and Stretto combination enables an improved user experience as an overlay to the most popular UC and IMS telephony and applications servers on the market today. Standards-based, cost-effective and reliable, CounterPath award-winning solutions power the voice and video calling, messaging, and presence offerings of customers such as AT&T, Avaya, BroadSoft, BT, Cisco Systems, GENBAND, Metaswitch Networks, Mitel, NEC, Network Norway, Nokia, Rogers and Verizon. Visit www.counterpath.com .

COUNTERPATH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Stated in U.S. Dollars)

July 31, April 30,
2016 2016
Assets (Unaudited)
Current assets:
Cash and cash equivalents $ 2,160,330 $ 2,159,738
Accounts receivable (net of allowance for doubtful accounts of $668,977 and $547,173, respectively) 3,191,848 3,209,279
Prepaid expenses and deposits 151,075 184,644
Total current assets 5,503,253 5,553,661
Deposits 95,080 93,868
Equipment 163,286 142,563
Goodwill 6,741,402 7,001,228
Other assets 176,938 174,811
Total Assets $ 12,679,959 $ 12,966,131
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued liabilities $ 2,007,915 $ 1,943,108
Accrued warranty 65,981 61,356
Customer deposits 6,357 2,384
Unearned revenue 1,987,491 1,808,857
Total current liabilities 4,067,744 3,815,705
Deferred lease inducements 31,573 35,379
Unrecognized tax benefit 10,563 10,563
Total liabilities 4,109,880 3,861,647
Stockholders' equity:
Preferred stock, $0.001 par value
Authorized: 100,000,000
Issued and outstanding: July 31, 2016 - nil; April 30, 2016 - nil - -
Common stock, $0.001 par value
Authorized: 10,000,000
Issued and outstanding:
July 31, 2016 - 4,555,048; April 30, 2016 - 4,542,348 4,555 4,542
Treasury stock - -
Additional paid-in capital 70,389,927 70,065,082
Accumulated deficit (58,386,411 ) (58,022,500 )
Accumulated other comprehensive loss - currency translation adjustment (3,437,992 ) (2,942,640 )
Total stockholders' equity 8,570,079 9,104,484
Liabilities and Stockholders' Equity $ 12,679,959 $ 12,966,131

COUNTERPATH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Stated in U.S. Dollars)

(Unaudited)

Three Months Ended
July 31,
2016 2015
Revenue:
Software $ 1,656,003 $ 1,200,849
Subscription, support and maintenance 955,296 838,138
Professional services and other 414,695 318,259
Total revenue 3,025,994 2,357,246
Operating expenses:
Cost of sales (includes depreciation of $1,806 (2015 - $1,806)) 497,116 481,932
Sales and marketing 961,869 1,187,033
Research and development 1,158,661 1,284,190
General and administrative 981,471 940,628
Total operating expenses 3,599,117 3,893,783
Loss from operations (573,123 ) (1,536,537 )
Interest and other income (expense), net:
Interest and other income 13 1,302
Interest expense - (1,631 )
Fair value adjustment on derivative instruments - (39,615 )
Foreign exchange gain 209,199 465,376
Net loss for the period $ (363,911 ) $ (1,111,105 )
Net loss per share:
Basic and diluted $ (0.08 ) $ (0.26 )
Weighted average common shares outstanding:
Basic and diluted 4,550,516 4,236,692

Non-GAAP Financial Measures

This news release contains "non-GAAP financial measures". The non-GAAP financial measures in this news release consist of non-GAAP income (loss) from operations which excludes non-cash stock-based compensation relative to gross profit and income (loss) from operations calculated in accordance with GAAP. The non-GAAP financial measures also include non-GAAP net income (loss) which excludes non-cash stock-based compensation and fair value adjustment on derivative instruments charges relative to income (loss) calculated in accordance with GAAP. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. CounterPath utilizes both GAAP and non-GAAP financial measures to assess what it believes to be its core operating performance and to evaluate and manage its internal business and assist in making financial operating decisions. CounterPath believes that the inclusion of non-GAAP financial measures, together with GAAP measures, provides investors with an alternative presentation useful to investors' understanding of CounterPath's core operating results and trends.

Reconciliation to GAAP

(Unaudited)

Three Months Ended
July 31,
2016 2015
Non-GAAP income (loss) from operations:
GAAP income (loss) from operations $ (573,123 ) $ (1,536,537 )
Plus:
Stock-based compensation 314,223 361,522
Non-GAAP income (loss) from operations $ (258,900 ) $ (1,175,015 )
Three Months Ended
July 31,
2016 2015
Non-GAAP net income (loss):
GAAP net income (loss) $ (363,911 ) $ (1,111,105 )
Plus:
Stock-based compensation 314,223 361,522
Fair value adjustment on derivative instruments - 39,615
Non-GAAP net income (loss) $ (49,688 ) $ (709,968 )
GAAP net income (loss) per share:
Basic and diluted $ (0.08 ) $ (0.26 )
Non-GAAP net income (loss) per share:
Basic and diluted $ (0.01 ) $ (0.17 )
CounterPath David Karp Chief Financial Officer (604) 628-9364 dkarp@counterpath.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leqembi Pen Revolutionizes Alzheimer's Care in Japan

Updated Category News Views 22

Innovative Alzheimer's Treatment Hits Japanese Market Just when you think the medical world needs a jolt of innovation, BioArctic rolls out something that could change how Alzheimer's is managed. With their subcutaneous Leqembi Pen, they've just added another feather in their cap, launching in Japan after a successful U.S. introduction. Not just your run-of-the-mill...

Continue Reading
Randi Baptiste Sets a New Standard in Youth Sports

Updated Category News Views 62

Youth Sports: Revolutionized by Randi Baptiste In an era where youth sports face a minefield of health risks and performance pressures, Randi Baptiste stands out. This isn't just about running around the park—this is about fundamentally transforming how we think about athletic development for young folks. Recognizing Baptiste for his contributions, The Inner Circle...

Continue Reading
Simform's AI Innovations Earns Microsoft Award Nod

Updated Category News Views 64

Riding the AI Wave with Simform In the chaotic world of AI and tech partnerships, earning recognition from a powerhouse like Microsoft ain't your run-of-the-mill achievement. Simform being recognized as a finalist for the 2026 Microsoft Innovate with Azure AI Apps and Agents Partner of the Year Award is a big deal, not just for them, but as a beacon of inspiration for...

Continue Reading
GAC's Green Push Unveils 3rd Showroom in Casablanca

Updated Category News Views 146

Pushing Through North Africa's Automotive Shift Well, looks like GAC is showing they're not just dabbling in North Africa—they're planting some sturdy roots in that rocky soil. Opening their third showroom in Casablanca, GAC isn't just settling for sidelines. They're step-in-the-ring serious about carving their name on North African roads. This isn't some skin-deep...

Continue Reading
Adam Foundation's Ramadan Effort to Cut Plastic Waste

Updated Category News Views 27

Environmental Consciousness: A Call from Antalya Here we go again, folks. Something refreshing is brewing over in Antalya at COP31, where the UK-based Adam Foundation has made a move that resonates beyond the usual hubbub. No smoke and mirrors, just straightforward action aimed at cutting down the wave of plastic waste during Ramadan. This isn't some pie-in-the-sky green...

Continue Reading
FF EAI Robotics Aims for Top Spot in K-12 Tech

Updated Category News Views 28

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Continue Reading
Rethinking Risk: AI, Cyber, and Ops Convergence

Updated Category News Views 28

Risk Management's New Frontier Hold onto your hats, folks, because the landscape of risk management is shifting under our feet—and not a minute too soon. With AI adoption skyrocketing, cybersecurity threats piling up like never-ending junk mail, and operational hurdles lurking around every corner, Wipfli's throwing down the gauntlet for business leaders to wise up....

Continue Reading
Implantica's Q3 2026: A Potential Leap Forward?

Updated Category News Views 34

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

Continue Reading
Squeez and Qentelli Join Forces to Revolutionize Loyalty

Updated Category News Views 438

A New Era of Loyalty Commerce The winds are changing in the loyalty game, and it's about time someone shook things up. Squeez has teamed up with Qentelli, thanks to a $1 million investment, to kick-start this next wave of commerce. And boy, it's not just about money—it's like combining brains with brawn. Squeez isn't just offering loyalty programs anymore; they're...

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading

Top 5 Most Recently Viewed Articles

Actinium Pharmaceuticals Faces Class Action Lawsuit for Losses

Updated Category News Views 198

Actinium Pharmaceuticals: A Closer Look at the Lawsuit Recently, a significant class action lawsuit was filed against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). This legal action is vital for investors who have experienced financial losses associated with their investments in Actinium's stock. The lawsuit, initiated by Pomerantz LLP, accuses the company and some of its...

Continue Reading
Uranium Energy Corp Delivers Promising Drill Results at Roughrider

Updated Category News Views 69

Uranium Energy Corp Unveils Outstanding Drilling Results Uranium Energy Corp (NYSE American: UEC) is thrilled to share the latest findings from its active drilling campaign at the Roughrider Project, which have revealed striking high-grade uranium mineralization. A drill hole positioned 850 meters northeast of the central Roughrider deposit has showcased remarkable...

Continue Reading
TME Pharma Presents Promising Glioblastoma Trial Outcomes

Updated Category News Views 159

TME Pharma's Progress in Glioblastoma Treatment TME Pharma N.V. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer. Recently, they announced an important oral presentation at a renowned medical congress, showcasing the encouraging results from the NOX-A12 GLORIA Phase 1/2 trial. This study aims to address glioblastoma, a...

Continue Reading
Life Time Champions Expanding Pickleball Facilities Across U.S.

Updated Category News Views 327

Life Time Champions Expanding Pickleball Facilities Across U.S. Life Time (NYSE: LTH) proudly marks World Pickleball Day as the sport continues to gain unprecedented popularity across America. With over 750 permanent pickleball courts established within its athletic country clubs, the organization demonstrates its commitment to being at the forefront of this dynamic...

Continue Reading
Edgewise Therapeutics Shares Breakthrough EDG-7500 Results

Updated Category News Views 305

Edgewise Therapeutics Announces Significant Progress in Hypertrophic Cardiomyopathy Treatment Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a pioneering biopharmaceutical company focused on muscle diseases, has recently disclosed positive outcomes from their Phase 2 CIRRUS-HCM trial studying EDG-7500. This treatment targets hypertrophic cardiomyopathy (HCM), a serious...

Continue Reading